Onconetix
ONCO
6 hedge funds and large institutions have $417K invested in Onconetix in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 4 → 6 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
13% less capital invested
Capital invested by funds: $479K → $417K (-$61.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$60.9K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$30.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$11K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.95K |
| 3 |
Bank of New York Mellon
New York
|
-$5.13K |
| 4 |
Two Sigma Advisers
New York
|
-$1.98K |
| 5 |
ODG
O'Dell Group
Cincinnati,
Ohio
|
-$23 |
ONCO Hedge Fund Activity: Q1 2024 in Review
6 of the 6,957 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q1 2024, worth a combined $417K — down 13% from $479K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ONCO positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cetera Investment Advisers, opening a new position worth an estimated $60.9K. The largest seller was Renaissance Technologies, cutting an estimated $11K.
- 6 institutional investors held Onconetix (ONCO) as of Q1 2024, up from 4 in Q4 2023.
- Funds reported $417K of Onconetix stock for Q1 2024, down 13% quarter-over-quarter.
- 2 funds opened new Onconetix positions in Q1 2024 and 0 closed out, a net change of +2 holders.
- The largest Onconetix buyer in Q1 2024 was Cetera Investment Advisers, an estimated $60.9K added.
- The largest Onconetix seller in Q1 2024 was Renaissance Technologies, an estimated $11K sold.
Based on aggregated 13F filings for Q1 2024.